Orexigen Therapeutics Inc (NASDAQ:OREX)

U.S. Markets are not yet open, but OREX is being traded in the pre-market session. Pre-Market quote »
4.04
Data as of Oct 01
 -0.22 / -5.16%
Today’s Change
4.01
Today|||52-Week Range
7.82
-28.24%
Year-to-Date

Today’s Trading

Previous close4.26
Today’s open4.26
Day’s range-- - --
Volume4,772,445
Average volume (3 months)3,830,047
Market cap$495.0M
Dividend yield--
Data as of 10/01/2014

Growth & Valuation

Earnings growth (last year)+37.01%
Earnings growth (this year)+109.06%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales158.47
Price/Book10.13

Competitors

 Today’s
change
Today’s
% change
AMPHAmphastar Pharmaceut...-0.53-4.55%
TTPHTetraphase Pharmaceu...+0.90+4.51%
SPPISpectrum Pharmaceuti...-0.05-0.61%
FLMLFlamel Technologies ...-0.07-0.49%
Data as of 10/01/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$3.4M
Annual profit (last year)-$77.7M
Net profit margin-2,265.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
CFO, Treasurer &
Chief Business Officer
Joseph P. Hagan
Corporate headquarters
La Jolla, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.